1. Home
  2. DXC vs LMAT Comparison

DXC vs LMAT Comparison

Compare DXC & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DXC Technology Company

DXC

DXC Technology Company

N/A

Current Price

$15.31

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

N/A

Current Price

$78.91

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DXC
LMAT
Founded
1959
1983
Country
United States
United States
Employees
115000
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
DXC
LMAT
Price
$15.31
$78.91
Analyst Decision
Hold
Buy
Analyst Count
8
8
Target Price
$12.50
★ $99.29
AVG Volume (30 Days)
★ 4.8M
256.3K
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
★ 1.26%
EPS Growth
N/A
★ 30.57
EPS
0.89
★ 2.07
Revenue
★ $12,644,000,000.00
$249,602,000.00
Revenue This Year
N/A
$10.59
Revenue Next Year
N/A
$9.93
P/E Ratio
★ $17.20
$38.28
Revenue Growth
N/A
★ 13.53
52 Week Low
$7.90
$78.22
52 Week High
$16.38
$118.01

Technical Indicators

Market Signals
Indicator
DXC
LMAT
Relative Strength Index (RSI) 59.62 43.43
Support Level $11.07 $78.35
Resistance Level $16.38 $83.68
Average True Range (ATR) 0.72 2.90
MACD -0.13 -0.52
Stochastic Oscillator 63.86 5.35

Price Performance

Historical Comparison
DXC
LMAT

About DXC DXC Technology Company

DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: